|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US7381825B2
(en)
|
2003-03-17 |
2008-06-03 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
ES2425083T3
(es)
*
|
2003-09-25 |
2013-10-11 |
Astellas Pharma Inc. |
Agente antitumoral que comprende FK228 como inhibidor de histona desacetilasa y doxorrubicina como inhibidor de topoisomerasa II
|
|
EP1712552A1
(en)
*
|
2005-04-11 |
2006-10-18 |
INDENA S.p.A. |
Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
|
|
US7446126B2
(en)
*
|
2004-10-08 |
2008-11-04 |
Indena S.P.A. |
Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
|
|
EP1824831A2
(en)
|
2004-12-16 |
2007-08-29 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
KR20080003334A
(ko)
*
|
2005-03-11 |
2008-01-07 |
더 리젠트스 오브 더 유니버시티 오브 콜로라도 |
암 세포를 표피 성장 인자 억제제에 대해 감작화시키는히스톤 데아세틸라제 억제제
|
|
US8999289B2
(en)
|
2005-03-22 |
2015-04-07 |
President And Fellows Of Harvard College |
Treatment of protein degradation disorders
|
|
EP1896436A2
(en)
|
2005-05-11 |
2008-03-12 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
EA200800321A1
(ru)
|
2005-07-14 |
2008-06-30 |
Такеда Сан Диего, Инк. |
Ингибиторы гистондеацетилазы
|
|
US8222423B2
(en)
|
2006-02-14 |
2012-07-17 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
|
WO2007095584A2
(en)
|
2006-02-14 |
2007-08-23 |
The President And Fellows Of Harvard College |
Histone Deacetylase Inhibitors
|
|
US8304451B2
(en)
|
2006-05-03 |
2012-11-06 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
GB0625283D0
(en)
*
|
2006-12-19 |
2007-01-24 |
Cyclacel Ltd |
Combination
|
|
US9408816B2
(en)
*
|
2006-12-26 |
2016-08-09 |
Pharmacyclics Llc |
Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
|
|
US20090131367A1
(en)
*
|
2007-11-19 |
2009-05-21 |
The Regents Of The University Of Colorado |
Combinations of HDAC Inhibitors and Proteasome Inhibitors
|
|
EP2231596A4
(en)
*
|
2007-12-14 |
2012-06-06 |
Univ Georgetown |
INHIBITORS OF HISTONATE ACETYLASE
|
|
AU2009274549B2
(en)
|
2008-07-23 |
2014-05-01 |
Dana-Farber Cancer Institute, Inc. |
Deacetylase inhibitors and uses thereof
|
|
GB2462893B
(en)
*
|
2008-08-29 |
2010-10-13 |
Bayer Schering Pharma Ag |
N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B
|
|
PT2350005E
(pt)
*
|
2008-08-29 |
2012-03-12 |
Bayer Pharma AG |
Polimorfo b de n-(2-aminofenil)-4-[n-(piridina-3-il)¿ metoxicarbonil-aminometil]-benzamida (ms-275)
|
|
ES2921576T3
(es)
|
2008-12-19 |
2022-08-29 |
Vertex Pharma |
Compuestos útiles como inhibidores de la quinasa ATR
|
|
EP2395972A4
(en)
*
|
2009-02-11 |
2014-02-12 |
Liangping Yu |
PARTICULATE COMPOSITION AND METHOD FOR PRODUCING THE SAME
|
|
RU2011142806A
(ru)
*
|
2009-05-01 |
2013-06-10 |
ОНКОЗИМ ФАРМА ИНК. (Канада) |
Комбинации пентамидина для лечения рака
|
|
KR20120031170A
(ko)
*
|
2009-06-08 |
2012-03-30 |
길리애드 사이언시즈, 인코포레이티드 |
알카노일아미노 벤즈아미드 아닐린 ｈｄａｃ 저해제 화합물
|
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
|
EP3103452A1
(en)
*
|
2009-08-25 |
2016-12-14 |
Abraxis BioScience, LLC |
Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
|
|
NZ603477A
(en)
|
2010-05-12 |
2014-09-26 |
Vertex Pharma |
Compounds useful as inhibitors of atr kinase
|
|
JP6330118B2
(ja)
|
2011-09-13 |
2018-05-30 |
ファーマサイクリックス エルエルシー |
ベンダムスチンと組み合わせたヒストンデアセチラーゼ阻害剤の製剤とその使用
|
|
CN106496173A
(zh)
|
2011-09-30 |
2017-03-15 |
沃泰克斯药物股份有限公司 |
用于制备可用作atr激酶抑制剂的化合物的方法
|
|
CN108685922A
(zh)
*
|
2011-09-30 |
2018-10-23 |
沃泰克斯药物股份有限公司 |
用atr抑制剂治疗胰腺癌和非小细胞肺癌
|
|
WO2013085902A1
(en)
*
|
2011-12-05 |
2013-06-13 |
The University Of Texas M.D. |
Combination therapy methods for treating an inflammatory breast cancer
|
|
CN108478577A
(zh)
|
2012-04-05 |
2018-09-04 |
沃泰克斯药物股份有限公司 |
可用作atr激酶抑制剂的化合物及其组合疗法
|
|
DK2904406T3
(en)
|
2012-10-04 |
2018-06-18 |
Vertex Pharma |
METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE
|
|
US9738637B2
(en)
|
2013-03-12 |
2017-08-22 |
Celgene Quantical Research, Inc. |
Histone demethylase inhibitors
|
|
US9963452B2
(en)
*
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
|
WO2015127227A1
(en)
*
|
2014-02-21 |
2015-08-27 |
Cleveland Biolabs, Inc. |
Uses of flagellin for improved chemotherapy
|
|
EP3194387B1
(en)
|
2014-09-17 |
2019-07-31 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
|
AU2016331955B2
(en)
|
2015-09-30 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
|
TWI808055B
(zh)
|
2016-05-11 |
2023-07-11 |
美商滬亞生物國際有限公司 |
Hdac 抑制劑與 pd-1 抑制劑之組合治療
|
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
|
|
US11596612B1
(en)
|
2022-03-08 |
2023-03-07 |
PTC Innovations, LLC |
Topical anesthetics
|
|
WO2025041160A1
(en)
*
|
2023-08-19 |
2025-02-27 |
Birla Institute Of Technology And Science (Bits), Pilani |
Bifunctional conjugate molecules for cancer treatment and process of making the same
|